| Idorsia Pharmaceuticals Ltd - QUVIVIQ 25 mg, Filmtabletten | | 68481 | | 01 | | QUVIVIQ 25 mg | | Filmtabletten | | N05CJ03 | | | | 01.12.2022 | | |
| | Composition | | daridorexantum 25 mg ut daridorexanti hydrochloridum, mannitolum, cellulosum microcristallinum, povidonum K 30, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, cellulosum microcristallinum, glycerolum, talcum, E 171, E 172 (rubrum), E 172 (nigrum) pro compresso obducto corresp. natrium 0.655 mg. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Daridorexantum | 25 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) pro Compresso Obducto | | | | (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Glycerol | | | | Hypromellosum | | Überzug | | Magnesii Stearas | | | | Mannitol | | | | Povidonum K | 30 | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 10 | | | B | | Oui | | 002 | 30 | | | B | | Non |
|
|
